SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Gorilla Technology Group, Inc. engages in the provision of video intelligence, Internet of Things (IoT) security, edge AI data analytics, and operational technology security solutions and services in Asia Pacific. It operates through the following segments: Video IoT, Security Convergence, and Other. The company was founded by Spincer Koh in May 2001 and is headquartered in London, the United Kingdom.

Gorilla Technology Group Inc

Gorilla Technology Group is currently trending as investors debate the impact of a newly announced multi-billion dollar AI infrastructure deal with Supermicro, which is being viewed as a significant validation of the company's growth strategy. While some community members highlight the potential for a massive short squeeze due to high short interest and a tight float, others remain focused on long-term execution risks and the company's capital requirements to fund such large-scale projects.

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

GameStop is trending after an unexpected early earnings report that featured the companys highest-ever quarterly net income and a new two billion dollar share repurchase authorization. The community is actively debating the significance of the buyback, with many bulls interpreting the news as a strategic move to squeeze short positions and defend the stock, while others remain skeptical about the firm's pivot toward e-commerce and its recent eBay-related investments.

Marvell Technology, Inc. engages in the design, development, and sale of integrated circuits. Its products include data processing units, security solutions, automotive, coherent DSP, DCI optical modules, ethernet controllers, ethernet PHYs, ethernet switches, linear driver, PAM DSP, transimpedance amplifiers, fibre channel, HDD, SSD controller, storage accelerators, ASIC, and Marvell government solutions. It operates through the following geographical segments: United States, Singapore, Israel, India, China, and Others. The company was founded by Wei Li Dai and Pantas Sutardja in 1995 and is headquartered in Wilmington, DE.

Marvell Technology Inc

Marvell Technology is experiencing a massive parabolic rally fueled by a high-profile endorsement from NVIDIA's CEO, who publicly highlighted its potential to reach a trillion-dollar valuation. The community is sharply divided between bulls riding the AI-driven momentum and skepticism from bears who view the move as a speculative gamma squeeze detached from fundamentals.

IREN Ltd. is a vertically integrated data center business powering the future of Bitcoin, AI and beyond with renewable energy. It is strategically located in renewable-rich, fiber-connected regions across the US and Canada. IREN’s large-scale, grid-connected facilities are purpose-built for the next generation of power-dense computing applications. The company was founded by Daniel Roberts and William Roberts on November 6, 2018, and is headquartered in Sydney, Australia.

IREN Ltd.

IREN Limited

IREN is seeing significant investor attention fueled by a $3.65 billion investment-grade financing facility to support its multi-year AI cloud contract with Microsoft. The community is actively debating the potential for a massive short squeeze as the stock hovers near critical resistance levels, with many focusing on the company's aggressive infrastructure expansion and its strategic alignment with the NVIDIA ecosystem.

Palo Alto Networks, Inc. engages in the provision of network security solutions to enterprises, service providers, and government entities. It operates through the following geographical segments: the United States, Israel, and Other Countries. The company was founded by Nir Zuk in March 2005 and is headquartered in Santa Clara, CA.

Palo Alto Networks Inc

Palo Alto Networks is seeing intense community focus following a strong earnings report that beat expectations, prompting a wave of bullish analyst upgrades and increased price targets. Investors are actively debating whether the stock's recent performance represents a durable AI-driven growth cycle or if the current valuation has become overextended following a significant pre-earnings rally.

BlackBerry Ltd. engages in the provision of intelligent security software and services. It operates through the following segments: QNX, Secure Communications, and Licensing. The QNX segment includes development of safe and reliable software for embedded systems across technology-driven industries. The Secure Communications segment delivers operational resiliency with a government-grade portfolio of secure, certified solutions for mobile fortification, critical communications and crisis management. The Licensing segment focuses on management and monetization of the firm's global patent portfolio. The company was founded by Michael Lazaridis, James Laurence Balsillie, and Douglas E. Fregin on March 7, 1984 and is headquartered in Waterloo, Canada.

BlackBerry Ltd

BlackBerry is seeing significant momentum as investors pivot toward its QNX software platform, which is increasingly viewed as a key player in physical AI and robotics rather than its legacy phone business. The community is actively debating the company's growth trajectory and potential for a squeeze, with many pointing to a growing royalty backlog and institutional accumulation as primary drivers for the recent surge.

LifeVantage Corp. engages in the identification, research, development, formulation, and sale of nutraceutical dietary supplements and personal care products. Its products include Protandim, Axio, TrueScience, PhysIQ, and Petandim. It operates through the Americas, and Asia or Pacific and Europe geographical segments. The company was founded in June 1988 and is headquartered in Lehi, UT.

Lifevantage Corporation

Lifevantage Corporation is gaining momentum as investors track a potential short squeeze fueled by an exceptionally high cost-to-borrow and limited share availability. The community is focused on the stock's constrained float and is actively debating whether current institutional short pressure will trigger an explosive move to the upside.

Meta Platforms, Inc. engages in the development of social media applications. It builds technology that helps people connect and share, find communities, and grow businesses. It operates through the Family of Apps (FoA) and Reality Labs (RL) segments. The FoA segment consists of Facebook, Instagram, Messenger, WhatsApp, and other services. The RL segment includes augmented, mixed and virtual reality related consumer hardware, software, and content. The company was founded by Mark Elliot Zuckerberg, Dustin Moskovitz, Chris R. Hughes, Andrew McCollum, and Eduardo P. Saverin on February 4, 2004, and is headquartered in Menlo Park, CA.

Meta Platforms Inc - Ordinary Shares - Class A

Meta Platforms Inc

Meta Platforms is facing intense volatility as investors debate the massive capital expenditure on AI infrastructure, with community sentiment split between those viewing the pullback as a buying opportunity and others concerned over long-term ROI. Market participants are actively discussing Meta's competitive positioning in AI versus peers, with some referencing recent endorsements from industry leaders while others highlight institutional concerns about spending levels and potential share dilution.

Aurinia Pharmaceuticals, Inc. is a clinical stage bio-pharmaceutical company, which engages in the research, development, and commercialization of therapeutic drugs. The company was founded by Robert Foster, Richard Glickman, and Michael Martin on June 16, 1993 and is headquartered in Edmonton, Canada.

Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals is trending following a series of significant share purchases by CEO Kevin Tang, which has sparked intense community speculation regarding a potential buyout or strategic shift. Investors are actively debating the company's future direction, expressing both anticipation for upcoming earnings and frustration over the lack of direct management communication since the leadership transition.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bear 3X ETF

Direxion Daily Semiconductor Bear 3X Shares

Direxion Daily Semiconductor Bear 3X Shares (SOXS) is attracting intense attention as retail investors struggle with the relentless, parabolic rise of the semiconductor sector driven by AI-related FOMO and concentrated momentum. The community is actively debating the sustainability of record-breaking sector valuations and the potential for a massive technical correction, while many grapple with the significant decay and losses associated with holding this inverse leveraged ETF in a one-sided bull market.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Abeona Therapeutics Q1 2026 Earnings Call: Complete Transcript

Abeona Reports Strong Q1 Revenue, Expands Treatment Center Network

Abeona Therapeutics Inc. (NASDAQ: ABEO) reported first-quarter earnings Wednesday before the market opened. Here's a rundown of the report.read more...

Abeona Therapeutics (ABEO) to Release Quarterly Earnings on Wednesday

Abeona Therapeutics (NASDAQ:ABEO) will be releasing its Q1 2026 earnings before the market opens on Wednesday, May 13. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-5-13-abeona-therapeutics-inc-stock...

Abeona Therapeutics Inc. (NASDAQ:ABEO) Given Consensus Recommendation of "Moderate Buy" by Brokerages

Shares of Abeona Therapeutics Inc. (NASDAQ:ABEO - Get Free Report) have been given a consensus rating of "Moderate Buy" by the five brokerages that are currently covering the firm, Marketbeat reports. One analyst has rated the stock with a sell rating and four have assigned a buy rating to the c...

2,000,000 Shares in Abeona Therapeutics Inc. $ABEO Purchased by AIGH Capital Management LLC

AIGH Capital Management LLC purchased a new position in Abeona Therapeutics Inc. (NASDAQ:ABEO - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm purchased 2,000,000 shares of the biopharmaceutical compa...

Abeona Therapeutics (NASDAQ:ABEO) Share Price Crosses Above 50 Day Moving Average - Here's What Happened

Abeona Therapeutics (NASDAQ:ABEO) Stock Price Crosses Above Fifty Day Moving Average - What's Next...

Aberdeen Group plc Makes New $3.25 Million Investment in Abeona Therapeutics Inc. $ABEO

Aberdeen Group plc acquired a new position in shares of Abeona Therapeutics Inc. (NASDAQ:ABEO - Free Report) in the 4th quarter, according to its most recent filing with the Securities & Exchange...

HC Wainwright Issues Pessimistic Outlook for ABEO Earnings

Abeona Therapeutics Inc. (NASDAQ:ABEO - Free Report) - Equities researchers at HC Wainwright decreased their Q1 2026 EPS estimates for Abeona Therapeutics in a report released on Thursday, March 19th. HC Wainwright analyst R. Selvaraju now anticipates that the biopharmaceutical company will post ear...

Abeona Therapeutics (NASDAQ:ABEO) Earns Buy Rating from HC Wainwright

HC Wainwright reiterated a "buy" rating and issued a $20.00 price target on shares of Abeona Therapeutics in a research report on Thursday...

Abeona Therapeutics Q4 Earnings Call Highlights

Abeona Therapeutics (NASDAQ:ABEO) executives said the company is seeing growing patient demand for ZEVASKYN, an autologous cell-based gene therapy approved in April 2025 for adults and pediatric...

Abeona Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development of gene therapy for severe and life-threatening rare diseases. It programs include EB-101 (gene-corrected skin grafts) for recessive dystrophic epidermolysis bullosa (RDEB), ABO-102 (AAV-SGSH), an adeno-associated virus (AAV) based gene therapy for Sanfilippo syndrome type A (MPS IIIA), and ABO-101 (AAV NAGLU), an AAV based gene therapy for Sanfilippo syndrome type B (MPS IIIB). The company was founded in 1974 and is headquartered in Cleveland, OH.

Fiscal Period	Estimated	Reported	Surprise	Result
Q2 '26	-$0.22	--	--	N/A
Q1 '26	-$0.34	-$0.30	10.45%	BEAT
Q4 '25	-$0.35	-$0.36	-2.27%	MISSED
Q3 '25	-$0.28	-$0.10	64.54%	BEAT
Q2 '25	-$0.39	$1.71	538.46%	BEAT

ABEOAbeona Therapeutics Inc

Fundamentals

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest Earnings Results: Q1 '26

Historical Earnings

Latest ABEO News